Every December, the San Antonio Breast Cancer Symposium brings together clinicians, researchers, and advocates to discuss the latest breast cancer study results. We’re proud to present our coverage below. We’ll be adding updates and links to the top of this page.
Research News
Untreated Long-Term Side Effects of Breast Cancer Treatment Can Lead to Anxiety, Depression
Adding Afinitor to Faslodex Helps Treat Metastatic Disease That’s AI-Resistant
Antidepressant Duloxetine Eases Joint Pain Caused by Aromatase Inhibitors
How Does Radiation Affect Reconstruction Results?
Preventive Medicine Helps Ease Diarrhea Side Effects With Neratinib
Herceptin Biosimilar Seems as Effective as Herceptin
Study Finds Side Effects of Experimental Buparlisib Too Toxic
Extending Aromatase Inhibitor Use Beyond 5 Years May Benefit Some Women
Scalp Cooling System Shown to Reduce Hair Loss During Chemotherapy
Podcasts
Radiation Effects on Reconstruction: Heard in the Halls
Marisa Weiss, M.D.
Overcoming Hormonal Therapy Side Effects: Heard in the Halls
Marisa Weiss, M.D.
Quality of Life With Metastatic Disease: Heard in the Halls
Leah Eshraghi
Male Breast Cancer Advocacy: Heard in the Halls
Michael Singer
Experimental Buparlisib Offers Benefits, But Side Effects Too Toxic
Ruth O’Regan, M.D.
Scalp Cooling: Heard in the Halls
Marisa Weiss, M.D.
Liquid Tumor Biopsies: Heard in the Halls
Philomena McAndrew, M.D.
New Scalp Cooling System Can Reduce Hair Loss From Chemotherapy
Julie Nangia, M.D.
Does 2.5 to 5 More Years of an Aromatase Inhibitor Offer Benefits? Maybe, For some Women
Terry Mamounas, M.D., M.P.H.
